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Abstract
Background: Meta-analysis is increasingly used as a key source of evidence synthesis to inform
clinical practice. The theory and statistical foundations of meta-analysis continually evolve,
providing solutions to many new and challenging problems. In practice, most meta-analyses are
performed in general statistical packages or dedicated meta-analysis programs.
Results: Herein, we introduce Meta-Analyst, a novel, powerful, intuitive, and free meta-analysis
program for the meta-analysis of a variety of problems. Meta-Analyst is implemented in C# atop of
the Microsoft .NET framework, and features a graphical user interface. The software performs
several meta-analysis and meta-regression models for binary and continuous outcomes, as well as
analyses for diagnostic and prognostic test studies in the frequentist and Bayesian frameworks.
Moreover, Meta-Analyst includes a flexible tool to edit and customize generated meta-analysis
graphs (e.g., forest plots) and provides output in many formats (images, Adobe PDF, Microsoft
Word-ready RTF). The software architecture employed allows for rapid changes to be made to
either the Graphical User Interface (GUI) or to the analytic modules.
We verified the numerical precision of Meta-Analyst by comparing its output with that from
standard meta-analysis routines in Stata over a large database of 11,803 meta-analyses of binary
outcome data, and 6,881 meta-analyses of continuous outcome data from the Cochrane Library of
Systematic Reviews. Results from analyses of diagnostic and prognostic test studies have been
verified in a limited number of meta-analyses versus MetaDisc and MetaTest. Bayesian statistical
analyses use the OpenBUGS calculation engine (and are thus as accurate as the standalone
OpenBUGS software).
Conclusion: We have developed and validated a new program for conducting meta-analyses that
combines the advantages of existing software for this task.
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Background
Systematic reviews of randomized controlled trials or epi-
demiological studies have emerged as a key source of evi-
dence across medical disciplines [1,2]. A central
component of many systematic reviews is meta-analysis,
the quantitative synthesis of information across method-
ologically and epidemiologically similar studies that
address the same research question. Meta-analysis
increases the statistical power to detect effects for which
individual studies may be underpowered. Reciprocally, in
the absence of statistically significant effects, it can
increase the power to exclude clinically important differ-
ences. Most importantly, meta-analytic methodologies-
particularly meta-regression, provide the framework to
quantify and explore between-study heterogeneity
(between-study dissimilarity) [3].
Meta-analysis is usually performed using computer pro-
grams. Herein we present a new program for the Microsoft
Windows operating system, Meta-Analyst, and report on
its testing versus other widely used and accepted software.
Meta-Analyst features an easy and intuitive graphical user
interface and has a spreadsheet-based layout. The pro-
gram was developed by the Tufts Evidence-based Practice
Center under contract with the US Agency for Healthcare
Research and Quality (AHRQ). It is available for use by
the AHRQ-designated Evidence-based Practice Centers for
performing meta-analyses in their evidence reports. Addi-
tionally, the software is now being made available to all
interested investigators worldwide at no cost. The latest
version can be obtained from http://tuftscaes.org/
meta_analyst/ (last accessed 11/12/2009).
Existing software
Meta-analysis can be performed in various general statisti-
cal and numerical analysis environments (e.g., Stata, R/
Splus, Octave/MATLAB), or in dedicated programs (e.g.,
the Microsoft DOS version of Meta-Analyst, Comprehen-
sive Meta-Analysis, RevMan, MIX [4]). A recent overview
[5] compared the features of 6 graphical user interface
packages dedicated to meta-analysis.
Two of the most popular dedicated meta-analysis pack-
ages are Comprehensive Meta-Analysis and MIX. The
former is a commercial product, costing $1295 for a
licence, while the latter is a free plug-in for the commercial
Microsoft Excel package. Both feature intuitive, spread-
sheet interfaces for data entry, and provide numerical and
graphical output in standard formats. However, both
implement only basic methods for the meta-analysis of
binary and continuous data (Table 1). In addition, they
do not handle meta-analysis of diagnostic and prognostic
test studies: for basic meta-analysis of diagnostic test stud-
ies, one would have to use yet another specialized pro-
gram, e.g., MetaDiSc [6] or MetaTest (Joseph Lau). To
perform more advanced analyses (such as random effects
meta-regression [7], bivariate diagnostic test meta-analy-
sis [8-10], or Bayesian analyses) one would have to care-
fully specify complicated model statements in a general
statistical programming environment.
As shown in Table 1, in Meta-Analyst strives to combine
the ease-of-use of standalone meta-analysis packages with
the advanced analytic capabilities offered by general sta-
tistical packages.
Implementation
Meta-Analyst is written primarily in C#, and runs atop
Microsoft's .NET framework. The .NET framework
allowed rapid development of an intuitive Windows-
based user interface. Data entry and management follows
the familiar Microsoft Excel©-like spreadsheet layout. We
use specialized open-source software libraries to create
plots (Zedgraph library for graphs and charts [11]) and
reports (iTextSharp [12] document generation toolkit).
Although the .NET Common Language Runtime is an
open standard, and therefore theoretically platform inde-
pendent, Meta-Analyst currently runs only on the Win-
dows operating system.
The design of Meta-Analyst is based on the Model-View-
Control design pattern [13], which emphasizes separating
the interface from the underlying algorithmic models.
This decoupling of the 'back-end' from the 'front-end'
allows rapid changes to be made to the Graphical User
Interface (GUI) without reworking the underlying statisti-
cal routines. Indeed, for testing purposes (discussed at
length in the Results section), we bypass the front-end
entirely and script tests via calls to the back-end. We plan
on allowing advanced users to utilize this functionality
directly, e.g., to run batch analyses. For example, Figure 1
displays sample code to perform a meta-analysis of binary
data with the Peto method on the data contained in
"my_data.csv".
For Bayesian analyses, we invoke OpenBUGS [14] on the
back-end and then present the output to the user via the
Meta-Analyst interface. Using OpenBUGS for Bayesian
analyses provides two major benefits: OpenBUGS is a
popular piece of software that has been thoroughly tested
by the statistical community. Second, it incorporates a
programming language that enables us to implement in
Meta-Analyst any model that can be fit in OpenBugs. We
use IronPython [15], an implementation of the Python
[16] programming language that runs on the .NET virtual
machine to facilitate rapid data processing and text
manipulation. This is particularly useful for file I/O and
for our interaction with the OpenBUGS library, which
requires us to generate model, data and initial value text
files dynamically and write them to disk (see Figure 2).BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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Table 1: Comparison of Meta-Analysis Software
Stata/WinBUGS R/OpenBUGS MIX CMA RevMan Meta-Analyst




Windows Windows Windows, Mac, 
Linux
Windows
Version 10 2.6 1.7 2 5.0.18 Beta 1.0
Price $785* FREE FREE $1,295 FREE FREE
Import data ✓✓ ✓ ✓ ✓
Meta-analysis interface/
routines
Macros Macros Dedicated Dedicated Dedicated Dedicated
Meta-regression ✓✓ ∅ ✓ ∅ ✓
Single group ✓✓ ✓ † ✓✓ † ✓
Fixed effects ✓✓ ✓ ✓ ✓✓
Random effects ✓✓ ✓ ✓ ✓✓
Multilevel models ✓✓ ∅∅ ∅ ✓
Random effects meta-
regression
✓✓ ∅∅ ∅ ✓
Bayesian models ✓✓ ∅∅ ∅ ✓
Cumulative meta-
analysis
✓✓ ✓ ✓ ∅ ✓
Subgroup analysis ✓✓ ∅ ✓✓ ✓
Small study effects 
(Publication bias 
tests)**
✓✓ ✓ ✓ ∅∅
Binary data ✓✓ ✓ ✓ ✓✓
Continuous data ✓✓ ✓ ✓ ✓✓
Diagnostic test data ✓✓ ∅∅ ✓✓
Multivariate ✓✓ ∅∅ ∅ ✓
Documentation of 
methods
✓✓ ✓ ✓ ✓✓
Forest plot ✓✓ ✓ ✓ ✓✓
Funnel plot ✓✓ ✓ ✓ ✓✓
SROC ✓✓ ∅∅ ✓✓
HSROC - bivariate 
meta-analysis
✓✓ ∅∅ ∅ ✓BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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Unlike other dedicated meta-analysis packages, Meta-
Analyst integrates the capabilities to perform meta-analy-
ses of binary or continuous outcomes and diagnostic or
prognostic tests, combining the functionality of software
such as MIX and Meta-DiSc. For each of these types of out-
comes, we have implemented standard meta-analysis rou-
tines, as well as some more advanced ones. Table 2
summarizes the analyses Meta-Analyst can currently per-
form.
Currently (as of version Beta 3.1) Meta-Analyst imple-
ments only one Bayesian model for each type of data
(binary, continuous and diagnostic; for model details see
http://tuftscaes.org/meta_analyst/AppendixA.html, last
accessed 11/12/2009). Because of the way we have inter-
faced Meta-Analyst with OpenBUGS (Figure 2) we can
easily add additional models.
For detailed explanation of the statistical routines used,
including handling of zero-cells, please see our methods
document at: http://tuftscaes.org/meta_analyst/
metaanalyst_methods.html (last accessed 1112/2009).
Exploratory and sensitivity analyses
Meta-Analyst automates cumulative meta-analysis,  leave-
one-out sensitivity analysis and subgroup analysis. In cumula-
tive meta-analysis one reorders the studies according to a
covariate (e.g., increasing year of publication) and re-esti-
mates the summary effect at each step, i.e., each time a
new study is added. It is typically a graphical analysis that
plots the aggregate overall estimate at each step [17,18].
This elucidates the evolution, or pattern, of evidence over
time. Leave-one-out analyses explore the influence of
individual studies as follows: If there are n studies in the
meta-analysis at hand, plot n summary estimates, each
corresponding to leaving one of the n studies out of the
calculation. This plot illuminates influential studies, as
when they are left out of the analysis, the overall estimate
will be notably perturbed. Subgroup analysis is a tool for
exploring the effects of a treatment on population sub-
groups, e.g., females older than 50 years old versus
younger women. This is done by conducting separate
meta-analyses on the respective subgroups and plotting
overall estimates for both.
Meta-Analyst generates different graphical output suitable
to the data at hand. Figures 3 and 4 summarize the plots
available.
Point and click plot 
editing
✓ ∅∅ ∅ ∅ ✓
Programming 
capabilities
✓✓ ∅∅ ∅ ✓
Leave one out 
sensitivity
✓✓ ∅ ✓ ∅ ✓
Results format RTF RTF MS Excel RTF, PowerPoint RevMan PDF, RTF, image 
files
* Intercooled Stata for a single processor, educational licence. Other versions are more expensive.
† One group analysis available for continuous outcomes only.
**Recent empirical research challenges the routine use of the so-called "publication bias diagnostics" [19-21].
RTF: Rich text format (can be opened in MS Word); SROC: summary receiver operating characteristic curve
Table 1: Comparison of Meta-Analysis Software (Continued)
Example call to the back-end from scripting environment Figure 1
Example call to the back-end from scripting environment.BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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User Interface
The GUI comprises two tabs; one for data entry and edit-
ing and the other for displaying the results of analyses (see
Figure 5). The help panel on the bottom of the tab is
always available and provides context-specific explana-
tions and instructions for the user. The main data manip-
ulation tool is a spreadsheet with a standard data-entry
interface. Data can either be entered by hand, or imported
from Excel (xls) or Comma Separated Value (csv) files via
an import 'wizard'. Meta-Analyst uses its own custom data
file format to save data, which bundles comma-separated
study data with some meta-data (for example, data type,
covariate names, etc.) about the meta-analysis.
While editing data, the outcome and corresponding con-
fidence intervals are updated dynamically. The outcome
metric can be changed via a right-click menu (e.g., from
odds ratio to risk difference) and the outcomes will be re-
computed automatically. While Figure 5 shows binary
data being manipulated, the interface is analogous for
continuous and diagnostic data.
The user can also provide additional numeric and string
variables that describe characteristics of the analyzed stud-
ies. By convention, user-added numeric variables are
termed covariates. Typically, covariates are used as explan-
atory variables in meta-regression analyses. To use covari-
ates in the analyses a user has to activate them (by right
clicking on the corresponding covariate name and choos-
ing the respective option). When at least one covariate is
activated, fixed and random effects meta-regression
becomes available as an analytic option in the program's
menus. If the covariate is excluded from the analyses,
meta-regression is not available as an option. To perform
meta-regression with several explanatory variables, the
user simply activates the corresponding covariates.
User-added string variables are termed labels and are typi-
cally used to provide textual descriptions, or to specify
subgroups for subgroup analyses. When a dataset contains
at least one label, the program allows the user to perform
subgroup analyses according to the categories defined by
the selected label. The subgroups are automatically
named according to the contents of the label. Labels are
ignored in meta-regression analyses (though displayed in
plots when pertinent). For example, suppose the user adds
a label "country". Further suppose that studies 1 and 2 are
labelled "United States" while studies 3 and 4 are labelled
"India". Then a subgroup analysis performed using the
"country" label will automatically plot the overall
(pooled) effects for the studies that were labelled as being
conducted in "India" (1 and 2) and the pooled estimate
will also be plotted for those labelled as being conducted
in the "United States" (3 and 4).
Studies can be included and excluded from a particular
analysis by selecting/deselecting the corresponding check-
box in the first column. Once the data is entered, the out-
come metric set and the studies and covariates desired to
be excluded from the analysis (if any) are deselected, users
can perform an analysis via the drop down 'Analysis'
menu, at which point they will be prompted with the dia-
logue shown in Figure 6. Here users can pick the model to
be used in the analysis, and specify the parameters for the
selected model. The program provides editable default
values for many of the options.
After the analysis runs to completion, the results will be
displayed in the results tab (Figure 7).
Schematic depiction of MetaAnalyst/BUGS interaction Figure 2
Schematic depiction of MetaAnalyst/BUGS interaction.BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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Table 2: Methods available in Meta-Analyst
Fixed Random Bayes
IV* MH Peto DL EM†
Binary outcomes
Odds ratio (OR) √√ √√ √√ ‡
Risk ratio (RR) √√ - √√ √ ‡
Risk difference (RD) √√ - √√ √ ‡
Proportion** √ -- √√ √ ‡
Continuous outcomes --
WMD √ -- √√ √ ‡
Hedge's g √ -- √√ √ ‡
Cohen's d √ -- √√ √ ‡
Glass' δ√ -- √√ √ ‡
Mean** √ -- √√ √ ‡
Diagnostic test data --
Specificity √ -- √√ √ ‡
Sensitivity √ -- √√ √ ‡
Accuracy √ -- √√ √ ‡
Positive predictive value (PPV) √ -- √√ √ ‡
Negative predictive value (NPV) √ -- √√ √ ‡
Positive likelihood ratio √√ - √√ √ ‡
Positive likelihood ratio √√ - √√ √ ‡
Diagnostic odds ratio √√ - √√ √ ‡
Summary ROC curve [weighted, unweighted] [weighted]
Bivariate --- - √
Hierarchical SROC - - √
*Fixed effects meta-regression using weighted least squares is available here if there is at least one numerical covariate.
†Random effects meta-regression using an expectation maximization approach is available here if there is at least one numerical covariate.
‡Control rate meta-regression (linear or quadratic) is possible here (with or without adjusting for additional covariates, as deemed appropriate).
** e.g., for the meta-analysis of data from single arm studies.
- = not applicable, √ = available, DL: DerSimonian and Laird model, EM = Expectation-maximization, IV = inverse variance, MH: Mantel-Haenszel 
method, ROC = Receiver operating characteristic curveBMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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The left-hand side of the results tab shows a tree popu-
lated with collapsible parent nodes for each analysis that
has been run ("Analysis 1" and "Analysis 2", in the figure).
Each of these parent nodes have child nodes correspond-
ing to the various tabular and graphical outputs associated
with the analysis. Clicking on one of these child nodes,
e.g., "Forest Plot", scrolls the corresponding graphic into
view.
All of the tables and graphics can be copied to the user's
clipboard via a right-click menu (and subsequently pasted
into other programs). Additionally, the tables and any text
therein can be edited and formatted via an embedded edi-
tor. Moreover, the user can edit forest plots using the forest
plot editor tool, as seen in Figure 8. Using this interface, the
user can change which columns are displayed in the forest
plot (e. g., study sizes), and in which order, as well as the
Plots available in Meta-Analyst Figure 3
Plots available in Meta-Analyst.BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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Plots available in Meta-Analyst Figure 4
Plots available in Meta-Analyst.BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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symbols used for point and overall estimates, the scale of
the plot (minimum and maximum) values and more.
In addition to the interactive output shown in Figures 7
and 8, Adobe© PDF and Microsoft© Word -ready Rich Text
Format report files are generated and saved. These include
all of the tabular and graphical output. Finally, the graph-
ics themselves are automatically output to separate image
(.PNG) files, for use in other programs. Our aim was to
provide the output in as many formats as possible, in
order to provide flexibility to the user.
Validation
To validate the computational results, we systematically
tested Meta-Analyst vs. the results from metan version 1.86
in Stata. We compared the output of the programs in
11,803 meta-analyses of binary outcomes and 6,881
meta-analyses of continuous outcomes from issue 4 of the
Cochrane Library of Systematic Reviews, 2005. This data-
base of meta-analyses was described elsewhere [19], and it
includes meta-analyses that have very different character-
istics.
Over the 11,803 analyses (over all methods and all met-
rics) for binary data and 6,881 analyses over continuous
data, we recorded the minimum of the absolute and nor-
malized differences between the outputs from Stata and
Meta-Analyst, where the normalized difference is defined
as Δrel = | ΘStata - ΘMA|/ΘStata. Θ is any of the numerical out-
put of the program such as a summary effect size for each
meta-analysis metric and method, its variance, and the Q,
τ2 and I2 statistics (for random effects models). We aimed
to identify differences that are beyond those introduced
by machine (im)precision. If there are such differences,
both the absolute and normalized difference between the
two numbers will be relatively large. When the numbers
in question are very large, the absolute difference might be
relatively large (merely because of machine imprecision)
whereas their normalized difference will be very small.
Reciprocally, for small magnitudes the normalized differ-
ence can be relatively large (in the absence of computa-
tional errors), while the absolute difference is very small.
Over the binary set of meta-analyses, the maximum dis-
crepancy was 2.9 × 10-6. For continuous data analyses, the
maximum discrepancy was 7.4 × 10-5. These maximum
Screenshot of the Data Entry screen in Meta-Analyst Figure 5
Screenshot of the Data Entry screen in Meta-Analyst.BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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discrepancies appeared in meta-analyses with extreme
between study heterogeneity, and are ascribed to round-
ing errors (version 1.86 of metan does not use double pre-
cision for all internal calculations as Meta-Analyst does).
As previously discussed, Bayesian analyses are run
through OpenBUGS, and so the output is as thoroughly
tested as OpenBUGS.
Testing for diagnostic test accuracy analyses is not as
extensive, because we have not found a suitable reference
scripting environment to test Meta-Analyst output against.
However, the simple diagnostic test methods are based on
weighted proportions (sensitivity, specificity), relative
risks (likelihood ratios), odds ratios and regression
(SROC, meta-regression). These methods use the same
computational algorithms as those for binary data and so
have been tested. Two diagnostic methods remain to be
sufficiently tested; bivariate meta-analysis of sensitivity
and specificity for diagnostic tests and random effects
SROC. These analyses are flagged as not thoroughly
checked when they are requested from the user. However,
these will soon be reconfigured to run in OpenBUGS so
that they will be validated as well.
Discussion
In order to attain widespread use, meta-analysis software
must be easy to use. In particular, requiring that users
learn an entire language to run their analyses will prohibit
general adaptation of a program. Dedicated meta-analysis
programs such as MIX, Comprehensive Meta-analysis,
and MetaDiSc are appealing due to their small learning
curve. On the other hand, by their very nature, such pro-
grams are less flexible than general statistical packages.
For example, they have no scripting functionality, which
precludes their use for large-scale empirical research or
simulation studies. Further, they are not able to perform
advanced analyses, such as bivariate diagnostic test meta-
analyses, because they cannot maximize difficult likeli-
hood functions, and they cannot be readily extended to
include additional analytic options.
Conclusion
Meta-Analyst mitigates several of the weaknesses inherent
to dedicated meta-analysis packages. It incorporates their
ease-of-use, while providing advanced analytic methods
that can be implemented in packages such as Stata, R and
SAS by a statistical programmer.
Binary analysis specifications Figure 6
Binary analysis specifications.BMC Medical Research Methodology 2009, 9:80 http://www.biomedcentral.com/1471-2288/9/80
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Results tab Figure 7
Results tab.
Forest Plot Editing Figure 8
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The current version of Meta-Analyst is made available free
of charge to interested researchers. It runs on any version
of Windows that is compatible with the .NET platform
(comprising Windows 98, ME, NT 4.0, 2000, XP and
Vista). We have already started development of a cross-
platform completely open-source version of the software
that uses the R statistical language, and will be readily
modifiable and extendable by any interested party http://
www.github.com/bwallace/OpenMeta-analyst-.
Availability and requirements
An installer file for the latest version of Meta-Analyst has
been provided as an additional/supplemental file for the
peer-reviewers [Additional File 1]. Alternatively, the latest
version can be obtained from http://tuftscaes.org/
meta_analyst/ (last accessed 11/12/2009). Meta-Analyst is
made readily available to any scientist wishing to use it for
non-commercial purposes, without any restriction
(including the need for a material transfer agreement).
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